Cognition-Enhancing Drugs: Can We Say No?

Bulletin of Science, Technology & Society, Vol. 30, No. 9, 2010

6 Pages Posted: 15 Jun 2010

Date Written: June 14, 2010

Abstract

Normative analysis of cognition-enhancing drugs frequently weighs the liberty interests of drug users against egalitarian commitments to a "level playing field." Yet those who would refuse to engage in neuroenhancement may well find their liberty to do so limited in a society where such drugs are widespread. To the extent that unvarnished emotional responses are world-disclosive, neurocosmetic practices also threaten to provide a form of faulty data to their users. This essay examines underappreciated liberty-based and epistemic rationales for regulating cognition-enhancing drugs.

Keywords: cognition-enhancing drugs

Suggested Citation

Pasquale, Frank A., Cognition-Enhancing Drugs: Can We Say No? (June 14, 2010). Bulletin of Science, Technology & Society, Vol. 30, No. 9, 2010, Available at SSRN: https://ssrn.com/abstract=1625028 or http://dx.doi.org/10.2139/ssrn.1625028

Frank A. Pasquale (Contact Author)

Brooklyn Law School ( email )

250 Joralemon Street
Brooklyn, NY 11201
United States

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
149
Abstract Views
2,043
rank
243,641
PlumX Metrics